MediPharm Labs (MEDIF) announced that David Pidduck will be stepping down from his role as the Company’s Chief Executive Officer, CEO, effective January 23rd, 2026. The Board of Directors has appointed Greg Hunter, the Company’s Chief Financial Officer, as Interim Chief Executive Officer, while it evaluates its long-term leadership plans. Hunter will continue to serve as Chief Financial Officer during this interim period. Pidduck will continue to serve on the Board
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEDIF:
- MediPharm Labs Names CFO Greg Hunter Interim CEO as Pidduck Steps Down
- MediPharm Labs Enters Costa Rica’s Medical Cannabis Market via Remidose Supply Deal
- Medipharm Labs enters supply agreement with Remidose
- MediPharm Labs Poised to Gain as U.S. Moves Cannabis to Schedule III
- Medipharm Labs ‘welcomes’ executive order on cannabis reclassification